Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Preservative-Free Brimonidine Tartrate vs Lumify in Ocular Redness
NCT05360784Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- May 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brimonidine in ocular redness, sponsored by Bausch + Lomb. Started May 2022; status: completed.
02
Drugs
brimonidine
03
Conditions
ocular redness
Beyond the preview
Go deeper on NCT05360784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05360784.